Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ENLV similar filings
- 16 Jul 19 Immunotherapy Company Enlivex Announces Dual Listing on the Tel-Aviv Stock Exchange
- 20 May 19 Condensed Consolidated Financial Statements
- 8 Apr 19 Report of Foreign Private Issuer
- 27 Mar 19 Securities Purchase Agreement
- 18 Mar 19 Current report (foreign)
- 6 Mar 19 Bioblast Announces Effectiveness of Eight to One Reverse
- 19 Feb 19 Asset Purchase Agreement
Filing view
External links
Exhibit 99.5
Consent of Independent Registered Public Accounting Firm
To the Board of Directors
Enlivex Therapeutics Ltd.
Gentlemen:
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-203114 and File No. 333-210459) of Enlivex Therapeutics Ltd. of our report dated July 24, 2018 relating to the financial statements of Enlivex Therapeutics Ltd. which appear in this Form 6-K.
/s/ Yarel + Partners
Yarel + Partners
Certified Public Accountants
Tel Aviv, Israel
March 26, 2019